RMS General Regression
|
|
119
|
32754
|
December 6, 2024
|
Using 2 different measures of the same entity for risk prediction
|
|
3
|
489
|
November 12, 2024
|
RMS Multivariable Modeling Strategies
|
|
67
|
30331
|
August 10, 2024
|
Discussion of Assessing Heterogeneity of Treatment Effect, Estimating Patient-Specific Efficacy, and Studying Variation in Odds ratios, Risk Ratios, and Risk Differences
|
|
33
|
12126
|
June 16, 2023
|
Interactions and random error
|
|
24
|
11598
|
October 20, 2022
|
Compare ORs between strata with log(OR) difference or use interactions?
|
|
0
|
1313
|
July 21, 2022
|
Relative excess risk due to interaction (RERI) from a multiplicative model
|
|
3
|
4151
|
April 20, 2022
|
Making sense of significant interaction with null main effect in RCT
|
|
3
|
11272
|
December 24, 2020
|
Basic question regarding model specification for interaction testing using a Cox PH Model
|
|
6
|
2900
|
September 23, 2020
|
Subgroup Interaction
|
|
2
|
4030
|
April 8, 2020
|
RCT generalizability and interactions with treatment
|
|
8
|
5090
|
March 10, 2020
|
Bayesian Modeling of Patient-Specific Efficacy Estimates and HTE
|
|
2
|
4041
|
July 2, 2019
|
How to display and tabulate interaction effects in a longitudinal model
|
|
1
|
5201
|
December 14, 2018
|